Sugi Predict

Sugi Predict / Compounds / SCHEMBL21884572

SCHEMBL21884572

SCHEMBL21884572

N#Cc1ccc(O)c(C(=O)NC(=N)N)c1-c1cccc(Cl)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33
▸ TAS1R2 Q8TE23 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PPIA P62937 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ MET P08581 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21884360 0.92 MEN1 (0.33) KDM4EKMT2APPIATSHRL3MBTL1
SCHEMBL21884434 0.91 L3MBTL1 (0.38) TAS1R3TAS1R1TAS1R2KDM4EKMT2A
SCHEMBL21884438 0.89 PPIA (0.33) TAS1R3TAS1R1TAS1R2KDM4EKMT2A
SCHEMBL21884394 0.89 MAPT (0.34) TAS1R3TAS1R1TAS1R2KDM4EKMT2A
SCHEMBL21884443 0.89 PPIA (0.38) KMT2APPIACNR2MEN1ALDH1A1
SCHEMBL21884659 0.86 PGR (0.38) KDM4EKMT2AL3MBTL1MEN1
SCHEMBL21884383 0.86 L3MBTL1 (0.38) TAS1R3TAS1R1TAS1R2KDM4EKMT2A
SCHEMBL21884355 0.86 AR (0.41) PPIAPTPN11
SCHEMBL21884631 0.85 ESR2 (0.36) KMT2APPIAMEN1SMN1; SMN2
SCHEMBL23854887 0.82 PKMYT1 (0.35) KMT2APPIATSHRMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371403-A1 SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS JNANA THERAPEUTICS INC. 2021-12-02 — — US disclosed
US-20210371403-A1 SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS JNANA THERAPEUTICS INC. 2021-12-02 — — US disclosed
US-20210299070-A1 METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY JNANA THERAPEUTICS INC. 2021-09-30 — — US disclosed
US-20210299070-A1 METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY JNANA THERAPEUTICS INC. 2021-09-30 — — US disclosed
WO-2020061473-A1 SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS JNANA THERAPEUTICS, INC. (US) 2020-03-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210299070-A1 METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY SLC19A1, SLC1A5, SLC1A2 TAS1R3 4172/4885TAS1R1 4078/4885TAS1R2 4055/4885
US-20210371403-A1 SMALL MOLECULES TARGETING MUTANT MAMMALIAN PROTEINS SNRPE, G3BP1, G3BP2 TAS1R3 4710/4885TAS1R1 4731/4885TAS1R2 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.